Measurements of Inflammation Induced by Allergen Inhalation Challenge in Mild Allergic Asthma
NCT06411886 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2024-05-13
Summary
This study will measure lung function tests and examine biological samples collected before and after inhaled allergen challenges and diluent (control) challenges in participants with mild allergic asthma.
Conditions
- Mild Asthma
Interventions
- DIAGNOSTIC_TEST
-
Allergen challenge
Inhaled allergen
- DIAGNOSTIC_TEST
-
Saline challenge
Inhaled saline
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Gail Gauvreau, PhD · McMaster University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-01
- Primary Completion
- 2026-03-31
- Completion
- 2026-03-31
Countries
- Canada
Study Locations
More Related Trials
-
Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma
NCT03620422 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen
NCT04187508 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma
NCT00410280 ·Status: COMPLETED ·Phase: PHASE2
-
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma
NCT00232999 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
NCT00595491 ·Status: RECRUITING ·Phase: PHASE1
-
Immune Dysfunction in Allergic Asthma
NCT00189228 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital
NCT00623688 ·Status: COMPLETED ·Phase: NA
-
Progression of Airway Obstruction in Childhood Asthma
NCT00873873 ·Status: COMPLETED
-
The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics
NCT00625989 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics
NCT02230189 ·Status: COMPLETED ·Phase: PHASE2
-
Functional Activity of Airway Eosinophils in Allergic Disease
NCT01026532 ·Status: COMPLETED
-
Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma
NCT00530062 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of SOLO Vibrating Mesh Nebulizer for Allergen-Induced Late Asthmatic Responses
NCT04630405 ·Status: UNKNOWN ·Phase: NA
-
Strategies to Improve Asthma and Treatment of Asthma in Canadians
NCT01525381 ·Status: COMPLETED
-
Airway Immune Response to Allergens (Use Lay Language Here)
NCT04619017 ·Status: UNKNOWN ·Phase: PHASE1
-
Inhaled Allergen Challenge Methodology: Assessment of a Vibrating Mesh Nebulizer for Allergen Administration
NCT03491358 ·Status: COMPLETED ·Phase: NA
-
A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)
NCT01343407 ·Status: COMPLETED ·Phase: PHASE1
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
Change in Airway Responsiveness After Allergen Exposure
NCT01699594 ·Status: COMPLETED ·Phase: NA
-
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
NCT06637371 ·Status: RECRUITING ·Phase: PHASE1
-
Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma
NCT00700726 ·Status: COMPLETED
-
Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
NCT00116311 ·Status: UNKNOWN
-
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
NCT00096616 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up of Mild Eosinophilic Asthma
NCT04650503 ·Status: UNKNOWN